Details for Luxembourg Supplementary Protection Certificate: 93314
✉ Email this page to a colleague
Luxembourg Supplementary Protection Certificate: 93314
Country | Patent Number | Supplementary Protection Certificate | SPC Country | SPC Description | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 1441589 | 93314 | Luxembourg | NAME: DACLIZUMAB; AUTHORISATION NUMBER AND DATE: EU/1/16/1107 20160705 | ⤷ Try a Trial |
>Country | >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Description | >SPC Expiration |